Plaintiffs' Firms From Zyprexa Case Seek More Fees

Two years after a $690 million settlement was reached in the multidistrict product liability suit over Eli Lilly & Co.'s blockbuster drug Zyprexa, four law firms that represented the plaintiffs have...

Already a subscriber? Click here to view full article